phosphonoacetic acid has been researched along with pyrophosphate in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (54.55) | 18.7374 |
1990's | 2 (18.18) | 18.2507 |
2000's | 2 (18.18) | 29.6817 |
2010's | 1 (9.09) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chan, WW; Hutchinson, DW; Laing, NM; Oberg, B | 1 |
Löfgren, B; Nordenfelt, E; Oberg, B | 1 |
Eriksson, B; Gadler, H; Oberg, B; Rudén, U; Wahren, B | 1 |
Hall, MJ | 1 |
Gillerman, E; Modak, MJ; Srivastava, A | 1 |
Eriksson, B; Oberg, B; Stening, G | 1 |
Eriksson, B; Helgstrand, E; Johansson, NG; Larsson, A; Oberg, B | 1 |
Nonay, RL; Reha-Krantz, LJ; Stocki, S | 1 |
Brook, CE; Harburn, JJ; Harris, WR; Peng, W; Spilling, CD; Srisung, S | 1 |
Bures, EJ; Kerwin, BA; Kohno, T; Latypov, RF; Raibekas, AA; Siska, CC | 1 |
Shears, SB; Wang, H; Weaver, JD | 1 |
1 review(s) available for phosphonoacetic acid and pyrophosphate
Article | Year |
---|---|
Structural insight into inositol pyrophosphate turnover.
Topics: Acid Anhydride Hydrolases; Catalytic Domain; Diphosphates; Humans; Inositol Phosphates; Molecular Docking Simulation; Phosphonoacetic Acid; Phosphotransferases (Phosphate Group Acceptor); Protein Binding; Protein Structure, Tertiary; Signal Transduction; Substrate Specificity | 2013 |
10 other study(ies) available for phosphonoacetic acid and pyrophosphate
Article | Year |
---|---|
Phosphorus-containing inhibitors of aspartate transcarbamoylase from Escherichia coli.
Topics: Aspartate Carbamoyltransferase; Aspartic Acid; Binding Sites; Diphosphates; Escherichia coli; Magnetic Resonance Spectroscopy; Molecular Structure; Phosphonoacetic Acid; Structure-Activity Relationship; Sulfhydryl Compounds | 1990 |
Inhibition of RNA- and DNA-dependent duck hepatitis B virus DNA polymerase activity by nucleoside and pyrophosphate analogs.
Topics: Animals; Antiviral Agents; Chick Embryo; Diphosphates; DNA-Directed DNA Polymerase; Foscarnet; Hepatitis B Virus, Duck; Nucleic Acid Synthesis Inhibitors; Nucleotides; Phosphonoacetic Acid; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase | 1989 |
Activity of the cytomegalovirus genome in the presence of PPi analogs.
Topics: Antiviral Agents; Cells, Cultured; Cytomegalovirus; Diphosphates; DNA Replication; DNA, Viral; Foscarnet; Humans; Nucleic Acid Synthesis Inhibitors; Organophosphorus Compounds; Phosphonoacetic Acid; Structure-Activity Relationship; Viral Proteins; Virus Replication | 1985 |
Anti-herpes virus combinations in relation to drug resistance.
Topics: Acyclovir; Adenosine Deaminase Inhibitors; Animals; Antiviral Agents; Diphosphates; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Foscarnet; Herpes Simplex; In Vitro Techniques; Nucleic Acid Synthesis Inhibitors; Phosphonoacetic Acid; Simplexvirus; Thymidine Kinase; Uridine Phosphorylase; Vidarabine | 1986 |
Observations on the phosphonoformic acid inhibition of RNA dependent DNA polymerases.
Topics: Diphosphates; Endonucleases; Foscarnet; Nucleic Acid Synthesis Inhibitors; Organophosphorus Compounds; Phosphonoacetic Acid; Pyridoxal Phosphate; Reverse Transcriptase Inhibitors; Ribonuclease H; Ribonucleases; Templates, Genetic | 1980 |
Inhibition of reverse transcriptase activity of avian myeloblastosis virus by pyrophosphate analogues.
Topics: Avian Leukosis Virus; Avian Myeloblastosis Virus; Diphosphates; Diphosphonates; DNA Polymerase II; Foscarnet; Kinetics; Phosphonoacetic Acid; Polydeoxyribonucleotides; Reverse Transcriptase Inhibitors; Structure-Activity Relationship | 1982 |
Pyrophosphate analogues as inhibitors of herpes simplex virus type 1 DNA polymerase.
Topics: Animals; Cattle; Diphosphates; DNA Polymerase II; Kinetics; Nucleic Acid Synthesis Inhibitors; Phosphonoacetic Acid; Simplexvirus; Structure-Activity Relationship | 1980 |
Bacteriophage T4 DNA polymerase mutations that confer sensitivity to the PPi analog phosphonoacetic acid.
Topics: Bacteriophage T4; Binding Sites; Dideoxynucleosides; Diphosphates; DNA Mutational Analysis; DNA Polymerase II; DNA Replication; DNA, Viral; Dose-Response Relationship, Drug; Foscarnet; Phosphonoacetic Acid; Structure-Activity Relationship | 1993 |
Effect of ligand structure on the pathways for iron release from human serum transferrin.
Topics: Binding Sites; Diphosphates; Humans; Hydrogen-Ion Concentration; Iron; Kinetics; Ligands; Magnetic Resonance Spectroscopy; Osmolar Concentration; Oxidation-Reduction; Phosphonoacetic Acid; Polyphosphates; Transferrin | 2005 |
Anion binding and controlled aggregation of human interleukin-1 receptor antagonist.
Topics: Affinity Labels; Anions; Binding Sites; Binding, Competitive; Cations; Citric Acid; Diphosphates; Hot Temperature; Humans; Interleukin 1 Receptor Antagonist Protein; Lysine; Mutagenesis, Site-Directed; Phosphates; Phosphonoacetic Acid; Protein Denaturation; Receptors, Interleukin-1; Recombinant Proteins; Sequence Deletion; Sialoglycoproteins; Signal Transduction; Structure-Activity Relationship | 2005 |